87 related articles for article (PubMed ID: 14685040)
1. [Immunotherapy by Japanese cedarpollen in atpic dermatitis].
Juji F; Kobayashi S; Ito S; Sugawara N; Kano H; Yasueda H; Iwata T
Arerugi; 2003 Nov; 52(11):1081-8. PubMed ID: 14685040
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
Masuda K
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):185-7. PubMed ID: 16098609
[TBL] [Abstract][Full Text] [Related]
3. Identification of peptides containing T-cell epitopes of Japanese cedar (Cryptomeria japonica) pollen allergen (Cry j 1) in dogs.
Masuda K; Sakaguchi M; Saito S; Yasueda H; Iwabuchi S; Tsukui T; Hayashi N; Nakao Y; Kurata K; Maeda S; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2004 Nov; 102(1-2):45-52. PubMed ID: 15451614
[TBL] [Abstract][Full Text] [Related]
4. [Japanese cedar pollinosis in infants in the allergy clinic].
Masuda S; Terada A; Fujisawa T; Iguchi K
Arerugi; 2000 Dec; 49(12):1138-45. PubMed ID: 11197879
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of sensitization of Japanese cedar pollen in children from infancy to adolescence].
Masuda S; Fujisawa T; Iguchi K; Atsuta J; Noma Y; Nagao M; Nambu M; Suehiro Y; Kamesaki S; Terada A; Mizuno M; Shimizu S; Tohda Y
Arerugi; 2006 Oct; 55(10):1312-20. PubMed ID: 17072111
[TBL] [Abstract][Full Text] [Related]
6. Japanese cedar pollen as an exacerbation factor in atopic dermatitis: results of atopy patch testing and histological examination.
Yokozeki H; Takayama K; Katayama I; Nishioka K
Acta Derm Venereol; 2006; 86(2):148-51. PubMed ID: 16648919
[TBL] [Abstract][Full Text] [Related]
7. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
Clin Exp Allergy; 2005 May; 35(5):664-71. PubMed ID: 15898991
[TBL] [Abstract][Full Text] [Related]
8. Airborne contact dermatitis due to Japanese cedar pollen.
Yokozeki H; Satoh T; Katayama I; Nishioka K
Contact Dermatitis; 2007 Apr; 56(4):224-8. PubMed ID: 17343624
[TBL] [Abstract][Full Text] [Related]
9. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens].
Silny W; Czarnecka-Operacz M; Silny P
Wiad Lek; 2005; 58(3-4):184-92. PubMed ID: 16119162
[TBL] [Abstract][Full Text] [Related]
12. CRTH2-dependent, STAT6-independent induction of cedar pollen dermatitis.
Oiwa M; Satoh T; Watanabe M; Niwa H; Hirai H; Nakamura M; Yokozeki H
Clin Exp Allergy; 2008 Aug; 38(8):1357-66. PubMed ID: 18477017
[TBL] [Abstract][Full Text] [Related]
13. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part I. Evaluation of clinical score].
Silny W; Czarnecka-Operacz M; Silny P
Wiad Lek; 2005; 58(1-2):47-55. PubMed ID: 15991553
[TBL] [Abstract][Full Text] [Related]
15. Changes in plasma TARC levels during Japanese cedar pollen season and relationships with symptom development.
Xiao JZ; Kondo S; Takahashi N; Odamaki T; Iwabuchi N; Miyaji K; Iwatsuki K; Enomoto T
Int Arch Allergy Immunol; 2007; 144(2):123-7. PubMed ID: 17536220
[TBL] [Abstract][Full Text] [Related]
16. The behaviour of immunoglobulins in children and adolescents hyposensitized for pollinosis and pollen asthma.
Hanasz-Jarzynska T; Kostanska H
Allergol Immunopathol (Madr); 1982; 10(1):11-6. PubMed ID: 7080992
[TBL] [Abstract][Full Text] [Related]
17. Analysis of helper T cell responses to Cry j 1-derived peptides in patients with nasal allergy: candidate for peptide-based immunotherapy of Japanese cedar pollinosis.
Masuyama K; Chikamatsu K; Ikagawa S; Matsuoka T; Takahashi G; Yamamoto T; Endo S
Allergol Int; 2009 Mar; 58(1):63-70. PubMed ID: 19050376
[TBL] [Abstract][Full Text] [Related]
18. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
[TBL] [Abstract][Full Text] [Related]
19. [Influence of the difference in the pollen count on medical costs in an allergen-specific immunotherapy for Japanese cedar pollinosis].
Yuta A; Miyamoto Y; Hattori R; Ogihara H; Takeuchi K; Majima Y
Arerugi; 2007 Nov; 56(11):1366-71. PubMed ID: 18059149
[TBL] [Abstract][Full Text] [Related]
20. Re-treatment with omalizumab at one year interval for Japanese cedar pollen-induced seasonal allergic rhinitis is effective and well tolerated.
Ogino S; Nagakura T; Okubo K; Sato N; Takahashi M; Ishikawa T
Int Arch Allergy Immunol; 2009; 149(3):239-45. PubMed ID: 19218816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
